Topic
clinical trial
Oxford University begins world-first human trial for Ebola vaccine
Researchers are conducting phase-one trials for the ChAdOx1 BDBV vaccine, which uses the same chimp-adenovirus vector as the Oxford/AstraZeneca COVID-19 jab.